Amalgamated Bank Viking Therapeutics, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 5,804 shares of VKTX stock, worth $229,606. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,804
Previous 5,744
1.04%
Holding current value
$229,606
Previous $152,000
2.63%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VKTX
# of Institutions
444Shares Held
66.5MCall Options Held
7.79MPut Options Held
3.25M-
Vanguard Group Inc Valley Forge, PA10MShares$396 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$238 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$149 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$128 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.58MShares$102 Million0.0% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.03B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...